These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8658619)

  • 21. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.
    Edinger M; Hoffmann P; Ermann J; Drago K; Fathman CG; Strober S; Negrin RS
    Nat Med; 2003 Sep; 9(9):1144-50. PubMed ID: 12925844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alleviation of acute and chronic graft-versus-host disease in a murine model is associated with glucocerebroside-enhanced natural killer T lymphocyte plasticity.
    Ilan Y; Ohana M; Pappo O; Margalit M; Lalazar G; Engelhardt D; Rabbani E; Nagler A
    Transplantation; 2007 Feb; 83(4):458-67. PubMed ID: 17318079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cytokine modulation of acute graft-versus-host disease.
    Ferrara JL
    Bone Marrow Transplant; 1998 Jun; 21 Suppl 3():S13-5. PubMed ID: 9712485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary T cell repertoire in patients with graft-versus-host disease following blood and marrow transplantation.
    Yurovsky VV; Cottler-Fox MH; Atamas SP; Shanholtz CB; Britt EJ; Sensenbrenner LL; White B
    Am J Hematol; 2001 Jan; 66(1):1-11. PubMed ID: 11426485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross species graft-versus-host disease induces hepatic injury in association with a donor-derived cellular immune response.
    Cooper MH; Nalesnik MA; Watkins SC; Schachter MJ; Ildstad ST
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1283. PubMed ID: 8442113
    [No Abstract]   [Full Text] [Related]  

  • 26. Th1 cytokines and NK cells participate in the development of murine syngeneic graft-versus-host disease.
    Flanagan DL; Jennings CD; Bryson JS
    J Immunol; 1999 Aug; 163(3):1170-7. PubMed ID: 10415011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oligoclonal expansion of T cell receptor V beta 2 and 3 cells in the livers of mice with graft-versus-host disease.
    Chen W; Howell CD
    Hepatology; 2002 Jan; 35(1):23-9. PubMed ID: 11786956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution.
    Gendelman M; Yassai M; Tivol E; Krueger A; Gorski J; Drobyski WR
    Biol Blood Marrow Transplant; 2003 Dec; 9(12):742-52. PubMed ID: 14677113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.
    Chen G; Wu D; Wang Y; Cen J; Feng Y; Sun A; Tang X; Chang H; Zhu Z
    Eur J Haematol; 2008 Sep; 81(3):226-35. PubMed ID: 18573173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Donor T cell and host NK depletion improve the therapeutic efficacy of allogeneic bone marrow cell reconstitution in the nonmyeloablatively conditioned tumor-bearing host.
    Hummel S; Wilms D; Vitacolonna M; Zöller M
    J Leukoc Biol; 2002 Nov; 72(5):898-912. PubMed ID: 12429711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct TCRAV and TCRBV repertoire and CDR3 sequence of T lymphocytes clonally expanded in blood and GVHD lesions after human allogeneic bone marrow transplantation.
    Hirokawa M; Matsutani T; Saitoh H; Ichikawa Y; Kawabata Y; Horiuchi T; Kitabayashi A; Yoshioka T; Tsuruta Y; Suzuki R; Miura AB; Sawada K
    Bone Marrow Transplant; 2002 Dec; 30(12):915-23. PubMed ID: 12476285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NK-KIR transcript kinetics correlate with acute graft-versus-host disease occurrence after allogeneic bone marrow transplantation.
    Denis L; Gagne K; Gueglio B; Kerdudou N; Milpied N; Simon P; Follea G; Bonneville M; Harousseau JL; Bignon JD
    Hum Immunol; 2005 May; 66(5):447-59. PubMed ID: 15935882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T cell immunity and graft-versus-host disease (GVHD).
    Ichiki Y; Bowlus CL; Shimoda S; Ishibashi H; Vierling JM; Gershwin ME
    Autoimmun Rev; 2006 Jan; 5(1):1-9. PubMed ID: 16338205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute graft-versus-host disease does not require alloantigen expression on host epithelium.
    Teshima T; Ordemann R; Reddy P; Gagin S; Liu C; Cooke KR; Ferrara JL
    Nat Med; 2002 Jun; 8(6):575-81. PubMed ID: 12042807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of graft-versus-host disease. Use of a T cell-controlled suicide gene.
    Helene M; Lake-Bullock V; Bryson JS; Jennings CD; Kaplan AM
    J Immunol; 1997 Jun; 158(11):5079-82. PubMed ID: 9164920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytokines in veno-occlusive disease of the liver after bone marrow transplantation.
    Remberger M; Ringdén O
    Transplant Proc; 1995 Dec; 27(6):3533-4. PubMed ID: 8540087
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhibition of natural killer (NK) cell prevents graft-vs-host-disease after small bowel transplantation in rats.
    Fujioka M; Tanaka S; Uda K; Makabe M; Orita T; Orita K
    Transplant Proc; 1992 Aug; 24(4):1507-8. PubMed ID: 1496637
    [No Abstract]   [Full Text] [Related]  

  • 38. Advances in GVHD: novel lymphocyte subsets and cytokine dysregulation.
    Ferrara JL
    Bone Marrow Transplant; 1992; 10 Suppl 1():10-2. PubMed ID: 1387830
    [No Abstract]   [Full Text] [Related]  

  • 39. [Graft versus host disease].
    Volc-Platzer B
    Hautarzt; 1992 Oct; 43(10):669-77. PubMed ID: 1428880
    [No Abstract]   [Full Text] [Related]  

  • 40. Analysis of the V beta T-cell receptor repertoire in autologous graft-versus-host disease.
    Ruvolo PP; Fischer AC; Vogelsang GB; Jones RJ; Hess AD
    Ann N Y Acad Sci; 1995 Jul; 756():432-4. PubMed ID: 7645866
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.